Category: Technology

  Alfa Cytology announced its pancreatic cancer research services for anticancer therapy in the early preclinical stages.   Alfa Cytology, a premier contract research organization, recently launched its full-scale pancreatic cancer research services with robust platforms, powerful analytics, and cross-platform collaborations.   Pancreatic cancer (PC) is a severe disease that is difficult to diagnose in the early stages due to its complex and hidden nature. Studies found that the incidence rate of PC has been increasing each year, especially in people over 45 years old. Even young patients suffering from PC…

Read More

    The development of monoclonal antibodies (mAbs) has completely transformed the field of medicine, providing targeted antidotes against a wide range of diseases, including cancer, autoimmune and infectious diseases. These therapeutic antibodies aim to specifically target antigens on the surface of cells and bind to them, leading to acidic reactions that result in the destruction of target cells.   The process of developing monoclonal antibodies begins with the identification of a suitable target antigen. This can be a protein or patch that is overexpressed on the face of cancer…

Read More

  CD BioSciences has announced its cytoskeleton-based tumor marker development service for cancer diagnosis. CD BioSciences, a prominent biotech company, has recently unveiled its latest and innovative service on cytoskeleton-based tumor marker development. This groundbreaking service can be utilized for preclinical tests to determine the tumor type and predict disease progression.   The cytoskeleton refers to the network of protein filaments within cells that plays a crucial role in maintaining their basic structure and performing actions. The structure, function, and dynamic behavior of the cytoskeleton may vary greatly depending on…

Read More

  CD BioSciences has announced its marine drug development services for anticancer therapies, pioneering a new frontier in novel drug R&D. Recently, CD BioSciences has announced the release of marine drug development services aiming to move forward the frontier of this area. Utilizing cutting-edge marine biological analysis techniques and unique platforms, CD BioSciences provides customers with tailored research services to produce efficient marine pharmaceutical products for cancer therapies.   “Our company is a biotechnology service provider of marine resource development and marine biological analysis. We hope to empower researchers to…

Read More

For a long time, the research and development of each new drug has faced the challenges of high cost and long cycle. In response to these challenges, major pharmaceutical companies have shifted from targeting common diseases to developing drugs for specific diseases. At the same time, these companies are constantly looking for new technologies for new drug development, such as high-throughput screening technology, DNA encoded chemical library, computer-aided drug discovery, and artificial intelligence. The use of computer simulation for drug development may reduce costs and increase the efficiency and success rate…

Read More

Nanogels (NGs), namely nanoscale hydrogel particles, are three-dimensional network systems formed by physical or chemical cross-linking of polymers. Nanogels have received widespread attention in recent years due to their unique properties and potential applications in various fields such as drug delivery, tissue engineering, and diagnostics. Classification of Nanogels According to the phase change triggering mechanism of nanogels, nanogels can be divided into ordinary nanogels and environment-responsive nanogels. Ordinary nanogels will swell when absorbing water, and their drug administration and subsequent release behavior will be single. Environmentally responsive nanogels will swell or…

Read More

Coupling drugs combine the precise targeting and potent killing properties, has become a widely recognized form of medication in recent years. Radioactive drug conjugates (RDCs), as a particular form of coupling drugs, are formed by combining radioactive isotopes with disease-targeting molecules. According to the application of RDCs, they can be divided into two main categories: diagnostic RDCs and therapeutic RDCs. γ-emitting isotopes are selected for diagnosis because the radiation they produce can be detected by specific instruments such as positron emission tomography (PET) or single-photon emission computed tomography (SPECT), assisting…

Read More